Clinical Trial Update: An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB). [Phase 3]

View source ↗

Summary

A Phase 3 extension study evaluated the safety and tolerability of a new drug in patients with symptoms of overactive bladder; study completed with posted resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• New Drug

Snippet

Sponsor: Urovant Sciences GmbH | Conditions: Overactive Bladder | Phase 3 | Status: COMPLETED | Results posted: 2021-02-03